Global Antithrombotic Drugs market size is predicted to grow from US$ 22200 million in 2025 to US$ 28840 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. Get Access Now!

Global Antithrombotic Drugs Market Size and Outlook 2025-31

The global Antithrombotic Drugs market size is predicted to grow from US$ 22200 million in 2025 to US$ 28840 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and also it causes pulmonary embolism. Deep vein thrombosis (DVT) and pulmonary embolism collectively called as venous thromboembolism (VTE). Deep vein thrombosis is usually affects legs, sometimes it also affects chest, arm and other parts of body. If it happens in brain, lungs and heart then that could cause damage of organ. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Antithrombotic Drugs Industry Forecast looks at past sales and reviews total world Antithrombotic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Antithrombotic Drugs sales for 2025 through 2031. With Antithrombotic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antithrombotic Drugs industry. This Insight Report provides a comprehensive analysis of the global Antithrombotic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antithrombotic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Antithrombotic Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antithrombotic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antithrombotic Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Antithrombotic Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Apixaban &nbsp;&nbsp;&nbsp; Debigatran &nbsp;&nbsp;&nbsp; Edoxaban &nbsp;&nbsp;&nbsp; Fondaparinux &nbsp;&nbsp;&nbsp; Heparin &nbsp;&nbsp;&nbsp; Rivaroxaban Segmentation by Application: &nbsp;&nbsp;&nbsp; General Pharmacies &nbsp;&nbsp;&nbsp; Hospital Pharmacies &nbsp;&nbsp;&nbsp; Online Retailers &nbsp;&nbsp;&nbsp; Drug Stores This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Bristol myers squibb pharma &nbsp;&nbsp;&nbsp; Abbott laboratories &nbsp;&nbsp;&nbsp; Pliva &nbsp;&nbsp;&nbsp; Sandoz &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Pharmacia &nbsp;&nbsp;&nbsp; Watson laboratories &nbsp;&nbsp;&nbsp; Zydus pharmaceuticals usa &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Key Questions Addressed in this Report What is the 10-year outlook for the global Antithrombotic Drugs market? What factors are driving Antithrombotic Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Antithrombotic Drugs market opportunities vary by end market size? How does Antithrombotic Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Antithrombotic Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Antithrombotic Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Antithrombotic Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Antithrombotic Drugs Segment by Type &nbsp;2.2.1 Apixaban &nbsp;2.2.2 Debigatran &nbsp;2.2.3 Edoxaban &nbsp;2.2.4 Fondaparinux &nbsp;2.2.5 Heparin &nbsp;2.2.6 Rivaroxaban &nbsp;2.3 Antithrombotic Drugs Sales by Type &nbsp;2.3.1 Global Antithrombotic Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Antithrombotic Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Antithrombotic Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Antithrombotic Drugs Segment by Application &nbsp;2.4.1 General Pharmacies &nbsp;2.4.2 Hospital Pharmacies &nbsp;2.4.3 Online Retailers &nbsp;2.4.4 Drug Stores &nbsp;2.5 Antithrombotic Drugs Sales by Application &nbsp;2.5.1 Global Antithrombotic Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Antithrombotic Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Antithrombotic Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Antithrombotic Drugs Breakdown Data by Company &nbsp;3.1.1 Global Antithrombotic Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Antithrombotic Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Antithrombotic Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Antithrombotic Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Antithrombotic Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Antithrombotic Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Antithrombotic Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Antithrombotic Drugs Product Location Distribution &nbsp;3.4.2 Players Antithrombotic Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Antithrombotic Drugs by Geographic Region &nbsp;4.1 World Historic Antithrombotic Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Antithrombotic Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Antithrombotic Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Antithrombotic Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Antithrombotic Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Antithrombotic Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Antithrombotic Drugs Sales Growth &nbsp;4.4 APAC Antithrombotic Drugs Sales Growth &nbsp;4.5 Europe Antithrombotic Drugs Sales Growth &nbsp;4.6 Middle East & Africa Antithrombotic Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Antithrombotic Drugs Sales by Country &nbsp;5.1.1 Americas Antithrombotic Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Antithrombotic Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Antithrombotic Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Antithrombotic Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Antithrombotic Drugs Sales by Region &nbsp;6.1.1 APAC Antithrombotic Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Antithrombotic Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Antithrombotic Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Antithrombotic Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Antithrombotic Drugs by Country &nbsp;7.1.1 Europe Antithrombotic Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Antithrombotic Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Antithrombotic Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Antithrombotic Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Antithrombotic Drugs by Country &nbsp;8.1.1 Middle East & Africa Antithrombotic Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Antithrombotic Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Antithrombotic Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Antithrombotic Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Antithrombotic Drugs &nbsp;10.3 Manufacturing Process Analysis of Antithrombotic Drugs &nbsp;10.4 Industry Chain Structure of Antithrombotic Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Antithrombotic Drugs Distributors &nbsp;11.3 Antithrombotic Drugs Customer 12 World Forecast Review for Antithrombotic Drugs by Geographic Region &nbsp;12.1 Global Antithrombotic Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Antithrombotic Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Antithrombotic Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Antithrombotic Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Antithrombotic Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Bristol myers squibb pharma &nbsp;13.1.1 Bristol myers squibb pharma Company Information &nbsp;13.1.2 Bristol myers squibb pharma Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.1.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Bristol myers squibb pharma Main Business Overview &nbsp;13.1.5 Bristol myers squibb pharma Latest Developments &nbsp;13.2 Abbott laboratories &nbsp;13.2.1 Abbott laboratories Company Information &nbsp;13.2.2 Abbott laboratories Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.2.3 Abbott laboratories Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Abbott laboratories Main Business Overview &nbsp;13.2.5 Abbott laboratories Latest Developments &nbsp;13.3 Pliva &nbsp;13.3.1 Pliva Company Information &nbsp;13.3.2 Pliva Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.3.3 Pliva Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Pliva Main Business Overview &nbsp;13.3.5 Pliva Latest Developments &nbsp;13.4 Sandoz &nbsp;13.4.1 Sandoz Company Information &nbsp;13.4.2 Sandoz Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.4.3 Sandoz Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Sandoz Main Business Overview &nbsp;13.4.5 Sandoz Latest Developments &nbsp;13.5 Pfizer &nbsp;13.5.1 Pfizer Company Information &nbsp;13.5.2 Pfizer Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.5.3 Pfizer Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Pfizer Main Business Overview &nbsp;13.5.5 Pfizer Latest Developments &nbsp;13.6 Pharmacia &nbsp;13.6.1 Pharmacia Company Information &nbsp;13.6.2 Pharmacia Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.6.3 Pharmacia Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Pharmacia Main Business Overview &nbsp;13.6.5 Pharmacia Latest Developments &nbsp;13.7 Watson laboratories &nbsp;13.7.1 Watson laboratories Company Information &nbsp;13.7.2 Watson laboratories Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.7.3 Watson laboratories Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Watson laboratories Main Business Overview &nbsp;13.7.5 Watson laboratories Latest Developments &nbsp;13.8 Zydus pharmaceuticals usa &nbsp;13.8.1 Zydus pharmaceuticals usa Company Information &nbsp;13.8.2 Zydus pharmaceuticals usa Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.8.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Zydus pharmaceuticals usa Main Business Overview &nbsp;13.8.5 Zydus pharmaceuticals usa Latest Developments &nbsp;13.9 Bristol-Myers Squibb &nbsp;13.9.1 Bristol-Myers Squibb Company Information &nbsp;13.9.2 Bristol-Myers Squibb Antithrombotic Drugs Product Portfolios and Specifications &nbsp;13.9.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Bristol-Myers Squibb Main Business Overview &nbsp;13.9.5 Bristol-Myers Squibb Latest Developments 14 Research Findings and Conclusion

Report	Global Antithrombotic Drugs Market Growth 2025-2031
Selected License	Single ID:LPI24016

Buyer Information

Order Summary